OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Related Posts
OpenAI appoints Dali Rajic as Chief Revenue Officer
OpenAI appoints Dali Rajic as Chief Revenue Officer to lead its global revenue organization and help businesses realize the full…
Working with the American Psychological Association on youth mental health and AI
OpenAI and the American Psychological Association advance evidence-based guidance, resources, and safeguards for responsible AI use and youth mental health.
OpenAI and Broadcom unveil LLM-optimized inference chip
OpenAI and Broadcom introduce Jalapeño, a custom AI chip built for LLM inference to improve performance, efficiency, and scale across…